Combined nested reverse transcription-PCR assay for prostate-specific antigen and prostate-specific membrane antigen in detecting circulating prostatic cells

Clinical Cancer Research

Volumn 3, Issue 7, 1997, Pages 1215-1220

  Zhang, Ying ^a   Zippe, Craig D ^a   Van Lente, Frederick ^a   Klein, Eric A ^a   Gupta, Manjula K ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ANTIGEN DETECTION; ARTICLE; BONE METASTASIS; CANCER STAGING; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTIGENS, NEOPLASM; ANTIGENS, SURFACE; CARBOXYPEPTIDASES; DNA, COMPLEMENTARY; FEMALE; GLUTAMATE CARBOXYPEPTIDASE II; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; NEOPLASM STAGING; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; REFERENCE VALUES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TREATMENT FAILURE; TUMOR CELLS, CULTURED;

EID: 0030794566     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Lu-Yao, G. L., Mclerran, D., Wasson, J., and Wennberg, J. E. An assessment of radical prostatectomy: time trends, geographic variation and outcomes. The Prostate Patient Outcome Research Team. J. Am. Med. Assoc., 269: 2633-2655, 1993.
2. Moreno, J. G., Croce, C. M., Fischer, R., Monne, M., Vihko, P., Mulholland, G., and Gomella, L. G. Detection of hematogenous micrometastasis in patients with prostate cancer. Cancer Res., 52: 6110-6112, 1992.
3. Deguchi, T., Doi, T., Ehara, H., Ho, S., Takahashi, Y., Nishino, Y., Fujihiro, S., Kawamura, T., Komeda, H., Horie, M., Kaji, H., Shimokawa, K., Tanaka, T., and Kawada, Y. Detection of micrometastatic prostate cancer cells in lymph nodes by reverse transcriptase polymerase chain reaction. Cancer Res., 53: 5350-5354, 1993.
4. Wood, D. P., Jr., Banks, E. R., Humphreys, S., McRoberts, J. W., and Rangnekar, V. M. Identification of bone marrow micrometastases in patients with prostate cancer. Cancer (Phila.), 74: 2533-2540, 1994.
5. Seiden, M. V., Kantoff, P. W., Krithivas, K., Propert, K., Bryant, M., Haltom, E., Gaynes, L., Kaplan, I., Bubley, G., DeWolf, W., and Sklar, J. Detection of circulating tumor cells in men with localized prostate cancer. J. Clin. Oncol., 12: 2634-2639, 1994.
6. Katz, A. E., Olsson, C. A., Raffo, A. J., Cama, C., Perlman, H., Seaman, E., O'Toole, K. M., McMahon, D., Benson, M. C., and Buttyan, R. Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay. Urology, 43: 765-775, 1994.
7. Jaakkola, S., Vornanen, T., Leinonen, J., Rannikko, S., and Stenman, U. Detection of prostatic cells in peripheral blood: correlation with serum concentrations of prostate-specific antigen. Clin. Chem., 41: 182-186, 1995.
8. Israeli, R. S., Miller, W. H., Jr., Su, S. L., Powell, T., Fair, W. R., Samadi, D. S., Huryk, R. F., DeBlasio, A., Edwards, E. T., Wise, G. J., and Heston, W. D. Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells: comparison of prostate-specific membrane antigen and prostate-specific antigen-based assays. Cancer Res., 54: 6306-6310, 1994.
9. Loric, S., Dumas, F., Eschwege, P., Blanchet, P., Benoit, G., Jardin, A., and Lacour, B. Enhanced detection of hematogenous circulating prostatic cells in patients with prostate adenocarcinoma by using nested reverse transcription polymerase chain reaction assay based on prostate-specific membrane antigen. Clin. Chem., 41: 1698-1704, 1995.
10. Israeli, R. S., Powell, T., Fair, W. R., and Heston, W. D. Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen. Cancer Res., 53: 227-230, 1993.
11. Israeli, R. S., Powell, T., Corr, J. G., Fair, W. R., and Heston, W. D. Expression of the prostate-specific membrane antigen. Cancer Res., 54: 1807-1811, 1994.
12. Olsson, C. A., de Vries, G. M., Raffo, A. J., Benson, M. C., O'Toole, K., Cao, Y., Buttyan, R. E., and Katz, A. E. Preoperative reverse transcriptase polymerase chain reaction for prostate specific antigen predicts treatment failure following radical prostatectomy. J. Urol., 155: 1557-1562, 1996.
13. Wainstein, M. A., He, F., Robinson, D., Kung, H-J., Schwartz, S., Giaconia, J. M., Edgehouse, N. L., Pretlow, T. P., Bodner, D., Kursh, E. D., Resnick, M. I., Seftel, A., and Pretlow, T. G. CWR22: androgen-dependent xenograft model derived from a primary human prostatic carcinoma. Cancer Res., 54: 6049-6052, 1994.
14. Cama, C., Olsson, C. A., Raffo, A. J., Perlman, H., Buttyan, R., O'Toole, K., McMahon, D., Benson, M. C., and Katz, A. E. Molecular staging of prostate cancer. II. A comparison of the application of an enhanced reverse transcriptase polymerase chain reaction assay for prostate specific antigen versus prostate specific membrane antigen. J. Urol., 153: 1373-1378, 1995.
15. Heston, W. D. Detection of hematogenous dissemination of prostatic cancer by RT-PCR with primers specific for prostate-specific membrane antigen (Editorial). Clin. Chem., 41: 1687-1688, 1995.
16. Sokoloff, M. H., Tso, C., Kaboo, R., Nelson, S., Ko, J., Dorey, R., Figlin, R. A., Pang, S., deKernion, J., and Belldegrun, A. Quantitative polymerase chain reaction does not improve preoperative prostate cancer staging: a clinicopathological molecular analysis of 121 patients. J. Urol., 156: 1560-1566, 1996.
17. Su, S. L., Huang, I., Fair, W. R., Powell, T., and Heston, W. D. W. Alternatively spliced variants of prostate-specific membrane antigen RNA: ratio of expression as a potential measurement of progression. Cancer Res., 55: 1441-1443, 1995.